Your browser doesn't support javascript.
loading
Plain language summary of the MonumenTAL-1 study of talquetamab in people with relapsed or refractory multiple myeloma.
Chari, Ajai; Askari, Elham; Caers, Jo; Costa, Luciano J; Hilder, Brandi W; Krishnan, Amrita; Mateos, María-Victoria; Minnema, Monique C; Oriol, Albert; Pillarisetti, Kodandaram; van de Donk, Niels W C J; Rodríguez-Otero, Paula.
Afiliação
  • Chari A; Mount Sinai School of Medicine, New York, NY, USA.
  • Askari E; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
  • Caers J; Centre Hospitalier Universitaire de Liège, Liege, Belgium.
  • Costa LJ; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Hilder BW; Janssen Research & Development, Spring House, PA, USA.
  • Krishnan A; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Mateos MV; University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain.
  • Minnema MC; University Medical Center Utrecht, University Utrecht, Utrecht, Netherlands.
  • Oriol A; Institut Català d'Oncologia & Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
  • Pillarisetti K; Janssen Research & Development, Spring House, PA, USA.
  • van de Donk NWCJ; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Rodríguez-Otero P; Clínica Universidad de Navarra, Navarra, Spain.
Future Oncol ; 19(27): 1823-1840, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37492991
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article